P1115

Very Early Intensive Treatment of HIV-Infected Infants  to Achieve HIV Remission: A Phase I/II Proof-of-Concept Study

Sponsors:
The National Institute of Allergy and Infectious Diseases (NIAD)
The Eunice Kennedy Shriver National Institute of Child Health and Human Development

Protocol Summary:
P1115 is a Phase I/II, multi-center, proof-of-concept study that will explore the effects of early intensive antiretroviral therapy on achieving HIV remission in neonates. The study will also assess the safety and pharmacokinetics of early intensive antiretroviral therapy in neonates.

Years: 2016 – present

Investigator: Mutsawashe Bwakura-Dangarembizi, MBChB, MMED, MSc Cli.Epi

Locations: Harare Family Care, Seke North, and St. Mary’s CRSs

IMPAACT

Current Study

Comments are closed.

Website by Canton Becker